Literature DB >> 14680802

Functional expression and characterization of an acidic actinoporin from sea anemone Sagartia rosea.

Xiaoyu Jiang1, Huiping Chen, Wenli Yang, Yun Liu, Wei Liu, Jianwen Wei, Hongbin Tu, Xiaojin Xie, Lei Wang, Anlong Xu.   

Abstract

Src I is the first reported acidic actinoporin from sea anemone Sagartia rosea with a pI value of 4.8 and comprises 13.9% alpha-helix, 65.1% beta-sheet, and 18.2% random coil. For structure-function studies, Src I was expressed in Escherichia coli as a cleavable fusion protein. Recombinant Src I exhibited obviously hemolytic activity, but the fusion protein Trx-Src I almost lost its hemolytic activity, suggesting the importance of the N-terminal amphiphilic alpha-helix for its functional activity. The cytotoxic effects of Src I depending on the toxin concentration and incubation time were also observed on cultured cells. Among five cell lines: NIH/3T3, U251, NSCLC, BEL-7402, and BGC-823, NSCLC was the most sensitive cells with ID(50) 2.8 microg/ml and BGC-823 was the least sensitive cells with ID(50) 7.4 microg/ml. After incubated with lipid SUVs, such as SM-SUVs and SM/PC-SUVs, the hemolytic activity of Src I was inhibited to some extent. When incubated with calcein-entrapped lipid LUVs, such as SM-LUVs, SM/PC-LUVs, and SM/PG-LUVs, Src I induced release of entrapped calcein. According to the interaction with lipid vesicles, we proposed that it was the membrane matrix made up of phospholipids, not a particular phospholipid that facilitates Src I to react properly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14680802     DOI: 10.1016/j.bbrc.2003.10.159

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  A pore-forming toxin requires a specific residue for its activity in membranes with particular physicochemical properties.

Authors:  Koldo Morante; Jose M M Caaveiro; Koji Tanaka; Juan Manuel González-Mañas; Kouhei Tsumoto
Journal:  J Biol Chem       Date:  2015-03-10       Impact factor: 5.157

2.  Oxidative Folding of Conopeptides Modified by Conus Protein Disulfide Isomerase.

Authors:  Lei Wang; Xiaomin Wang; Zhenghua Ren; Wei Tang; Qiong Zou; Jinxing Wang; Shangwu Chen; Han Zhang; Anlong Xu
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

3.  Biologically active and C-amidated hinnavinII-38-Asn produced from a Trx fusion construct in Escherichia coli.

Authors:  Chang Soo Kang; Seung-Yeol Son; In Seok Bang
Journal:  J Microbiol       Date:  2008-12-24       Impact factor: 3.422

4.  Overexpression and Enzymatic Assessment of Antigenic Fragments of Hyaluronidase Recombinant Protein From Streptococcus pyogenes.

Authors:  Shabnam Sadoogh Abbasian; Ehsanollah Ghaznavi Rad; Neda Akbari; Mohammad Reza Zolfaghari; Iraj Pakzad; Hamid Abtahi
Journal:  Jundishapur J Microbiol       Date:  2014-12-09       Impact factor: 0.747

5.  Evaluating cytotoxic effects of recombinant fragaceatoxin C pore forming toxin against AML cell lines.

Authors:  Mahnaz Azadpour; Maedeh Karimian; Mohammad Hassan Kheirandish; Abolghasem Asadi-Saghandi; Mehdi Imani; Akram Astani; Hossein Zarei Jaliani
Journal:  Iran J Basic Med Sci       Date:  2018-09       Impact factor: 2.699

Review 6.  Functional and Structural Variation among Sticholysins, Pore-Forming Proteins from the Sea Anemone Stichodactyla helianthus.

Authors:  Esperanza Rivera-de-Torre; Juan Palacios-Ortega; J Peter Slotte; José G Gavilanes; Álvaro Martínez-Del-Pozo; Sara García-Linares
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

Review 7.  Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Toxins (Basel)       Date:  2013-12-27       Impact factor: 4.546

8.  Actinoporin-like Proteins Are Widely Distributed in the Phylum Porifera.

Authors:  Kenneth Sandoval; Grace P McCormack
Journal:  Mar Drugs       Date:  2022-01-15       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.